Bristol-Myers Squibb Company
UEI: UFGKB2B71N12
• CAGE: 4K2D9
Overview
Awardee Type
Parent
Company Description
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
Name
Bristol-Myers Squibb Company
Website
Headquarters
Lawrenceville, NJ
United States
United States
Most Recent Award
March 19, 2025
Calculating
Federal contract recipient
BRISTOL-MYERS SQUIBB COMPANY
(UEI UFGKB2B71N12, CAGE 4K2D9)
is headquartered in Lawrenceville NJ.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 1853 and
federally registered in
September 2006.
Federal Award Analysis
Bristol-Myers Squibb Company federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
BRISTOL-MYERS SQUIBB COMPANY
Division Name
BRISTOL MYERS SQUIBB
UEI
UFGKB2B71N12
CAGE Code
4K2D9
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 1853
Initial Registration
Sept. 26, 2006
Last Registration
Oct. 15, 2024
Registration Activation
Oct. 15, 2024
Registration Expiration
Oct. 11, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Disaster Registry
Nationwide
Reported NAICS
Reported PSC
Accepts Credit Cards
Yes
People
Vendor contacts at Bristol-Myers Squibb Company
GSA Schedules and Price Lists
- Bristol-Myers Squibb Company
- PoP: 4/30/24 - 4/30/29
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $7,124,866
- View | Download
- Bristol-Myers Squibb Company
- PoP: 4/30/18 - 4/30/24 (Ended)
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Obligated: $3,141,563